SCHEMBL4379159

SCHEMBL4379159

COc1ccc(CCCC(=O)N2CCN(C3CCCCC3)CC2)cc1

nearest known ligand 0.87

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.87
▸ TSHR P16473 1/20 0.87
▸ KMT2A Q03164 1/20 0.87
▸ HPGD P15428 2/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2D6 P10635 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ GAA P10253 2/20 0.53
▸ FKBP1A P62942 1/20 0.53
▸ RAB9A P51151 1/20 0.52
▸ KDM4E B2RXH2 5/20 0.50
▸ ORAI1 Q96D31 1/20 0.49
▸ SIGMAR1 Q99720 1/20 0.49
▸ PKM P14618 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4378477 0.99 ALDH1A1 (0.84) ALDH1A1TSHRKMT2AHPGDCYP1A2
Hydrochloric Acid SCHEMBL4379167 0.98 ALDH1A1 (0.83) ALDH1A1TSHRKMT2AHPGDCYP1A2
SCHEMBL4384079 0.93 ALDH1A1 (1.00) ALDH1A1TSHRKMT2AHPGDSMN1; SMN2
SCHEMBL4383272 0.92 ALDH1A1 (0.98) ALDH1A1TSHRKMT2ASMN1; SMN2GAA
SCHEMBL2833214 0.89 KMT2A (0.69) ALDH1A1TSHRKMT2AHPGDCYP1A2
SCHEMBL4384250 0.85 KMT2A (0.64) ALDH1A1TSHRKMT2ARAB9A
SCHEMBL31329285 0.85 HPGD (0.66) ALDH1A1TSHRKMT2AHPGDCYP1A2
SCHEMBL31329313 0.85 HPGD (0.66) ALDH1A1TSHRKMT2AHPGDCYP1A2
SCHEMBL4375522 0.84 KMT2A (0.62) ALDH1A1TSHRKMT2ARAB9AKDM4E
SCHEMBL31329327 0.84 FKBP1A (0.64) ALDH1A1TSHRKMT2AHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 — — EP claimed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 — — EP disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 — — US disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 — — US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 — — US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 ALDH1A1 1907/4885TSHR 621/4885KMT2A 295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback